Vivo Bio Tech Ltd
VIVO

Vivo Bio Tech Ltd (511509)

₹330.76%

Key Stats

₹32.15
Day's Price Range
₹33.45
₹26.25
52-Week Price Range
₹103.95
1 Month Return6.67 %
3 Month Return-14.38 %
1 Year Return-60.04 %

Company Financials

  • Quarterly
  • Annual
Value in ₹ crore

Peer Comparsion

PE
Rank 144
21.12
EPS
Rank 219
₹1.54
BVPS
Rank 227
₹30.63
Dividend Yield
Rank 176
ROE
Rank 160
15.03%
Price To Book Ratio
Rank 49
1.06
Debt To Asset
Rank 165
0.46

Company Information

Vivo Bio Tech is a full service CRO offering drug development discovery services to pharmaceutical biotech companies worldwide in accordance with OECD AAALAC IND guidelines. The company offers services in the areas of In vitro In vivo toxicity studies pharmacological investigations pharmacokinetics toxicokinetic studies etc. Our experienced talented scientists offer advice on defining drug development paths tailored to specific molecules. Tailored and dedicated to our clients we distinguish your development plan is as superlative as the products you bring to our testing facilities.The Biologic Research Services group at Vivo Bio Tech offers a complete line of protein services including gene synthesis cloning expression and purification of recombinant proteins and monoclonal antibodies. Our scientists will team up with you to develop solution for the most difficult to deal products including purification of untagged poorly expressed proteins.Invitro Services offers solutions for pharmacologic toxicological bioanalytical investigations in drug discovery development. Critical investigations like bacterial reverse mutation assays chromosomal aberration and micronucleus are specialty services by our scientists.The Invivo Services group at Vivo Bio Tech provides both nonregulatory and regulatory IND enabling preclinical development services. We are capable of screening evaluating molecules for various pharmacological therapeutic properties. Specifically for oncology our scientists can provide design development of xenograft models for evaluation of anticancer agents. Further our scientists can customize invivo DMPK studies to help profile your drug candidate in both rodent and nonrodent animal models.Vivo Bio has partnered with Taconic for sourcing foundation and expansion colonies of the animal models and have started inhouse breeding of Specific Pathogen Free rodents.
OrganisationVivo Bio Tech Ltd
HeadquartersGajel
IndustryPharmaceuticals